EDITORIAL
From precision oncology to molecular prevention – a new role for our profession?
As rapid scientific and technological progress raises hopes of more cancers being intercepted at the earliest stages in the future, ESMO delves deeper into prevention to ensure education and guidance for medical oncologists in this moving field
CONGRESS HIGHLIGHTS
Promising results reported for novel antiangiogenic agents for neuroendocrine tumours
The fields of metastatic pancreatic NETs and advanced and low proliferative grade 3 disease tumours move forward
Novel immunotherapeutics suggest promise in high-grade gliomas
Results from early-phase studies reveal potential for a new cancer vaccine and adaptive immunotherapy
Further support for durvalumab consolidation as a new standard of care in limited-stage SCLC
Subgroup analyses from the ADRIATIC study support previous practice-changing findings
2024 ESMO SOCIETY AWARDS
Improving supportive care of young patients with breast cancer
According to Prof. Ann Partridge, 2024 ESMO Awardee, young patients with breast cancer have unique needs that must be addressed to achieve better outcomes
Role of female leaders in addressing gender gaps in oncology
ESMO Women for Oncology Award Recipient Prof. Myung Hu Ahn discusses gender equity in lung cancer research
Translational research: from bytes to bedside
According to Prof. Serena Nik-Zainal, 2024 ESMO Translational Research Awardee it is important to change the mindset of the cancer community to embrace all the information available through genome research
ESMO INITIATIVES
Is gender equity still an issue in oncology?
At the ESMO Congress 2024, the ESMO Women for Oncology (W4O) Committee is presenting new findings on female representation in leadership positions
Tumour-agnostic oncology – time has come to re-think clinical research
Advances in precision oncology are moving the field towards a biology-based cancer care, and ESMO is supporting the change with a series of tailored resources for medical oncologists
Cancer in old patients: geriatric assessment and management plays a crucial role to provide personalised care
First recommendations are released from the ESMO/SIOG Cancer in the Elderly Working Group
COLUMNS
How to mark a tangible impact in cancer control
Recent research shows that tailored strategies and political commitment can revert current epidemiology trends of cancer
The sunscreen dilemma – how to make skin cancer prevention environmentally friendly?
The use of sunscreens is essential to protect the skin from UV exposure, but they may enter waterways damaging the ecosystem
OPINIONS
Choose the right treatment, at the right dose – a way to create a financially-sustainable cancer care?
Angela Lamarca
Do young patients benefit from immune checkpoint inhibitors?
Andrea Ferrari
OPINIONS
Choose the right treatment, at the right dose – a way to create a financially-sustainable cancer care?
Angela Lamarca
Do young patients benefit from immune checkpoint inhibitors?
Andrea Ferrari